Search clinical trials for: Warfarin 3mg

Total 12775 results

British Thoracic Society

Completed

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

Deep Vein Thrombosis | Pulmonary Embolism | Deep Vein Thrombosis With Pulmonary Embolism

United Kingdom
Texas Cardiac Arrhythmia Research Foundation
Stanford University; Case Western Reserve University; University of Kansas; California... and other collaborators

Completed

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE)

Thromboembolism

United States
De Montfort University
University Hospitals, Leicester

Unknown

Model-based Versus Traditional Warfarin Dosing in Children (WATCH)

Congenital Heart Defects
National Heart, Lung, and Blood Institute (NHLBI)
Bristol-Myers Squibb

Completed

Clarification of Optimal Anticoagulation Through Genetics (COAG)

Stroke | Venous Thrombosis | Atrial Fibrillation | Atrial Flutter

United States
Johns Hopkins University

Completed

Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

Atrial Fibrillation | Bradycardia | Tachycardia | Valvular Heart Disease

United States
Intermountain Health Care, Inc.

Completed

Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin (Coumagen-II)

Thromboembolism

United States
University of Alberta
Heart and Stroke Foundation of Canada; Canadian Stroke Prevention Intervention...

Completed

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing (PIAAFRx)

Stroke | Atrial Fibrillation

Canada
Bial - Portela C S.A.

Completed

Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Healthy

Portugal
Boehringer Ingelheim

Completed

Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers

Healthy
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
Hamilton Health Sciences Corporation

Completed

Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

Thrombosis | Bleeding | End Stage Renal Disease

Canada
Chinese University of Hong Kong
Professor Bryan Ping Yen YAN (byan)

Recruiting

Warfarin Dosage Adjustment Model Analysis Study

Warfarin

Hong Kong
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects

Healthy
Wuhan Asia Heart Hospital

Unknown

AI-based Social Software to Manage wARfarin Therapy (AI-SMART)

Anticoagulant-induced Bleeding | Warfarin Sodium Causing Adverse Effects in Therapeutic Use

China
Boehringer Ingelheim

Completed

Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy Volunteers

Healthy

Germany
First Affiliated Hospital Xi'an Jiaotong University

Withdrawn

Gene-guided Warfarin for Anticoagulation Therapy (GWAT)

Stroke
University of Padova

Completed

Early Identification of Warfarin Maintenance Dosage

Atrial Fibrillation

Italy
ARYx Therapeutics

Unknown

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation (EmbraceAC)

Myocardial Infarction | Atrial Fibrillation | Atrial Flutter | Cardiomyopathy | Venous Thromboembolic Disease

United States
University Hospital, Bonn
German Research Foundation; German Federal Ministry of Education and Research

Unknown

D-Dimer Guided Oral Anticoagulant Treatment (OAT) (DDOAT2006)

Deep Venous Thrombosis

Germany
Cedars-Sinai Medical Center
National Institute on Aging (NIA)

Recruiting

A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF (APOTHECARYAF)

Stroke | Atrial Fibrillation

United States
Boehringer Ingelheim

Completed

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

Canada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
Helixmith Co., Ltd.

Completed

Safety Study of Gene Therapy in Treating Lower Leg Ischemia

Critical Limb Ischemia

United States
University of North Carolina, Chapel Hill
UNC Institute for Pharmacogenomics and Individualized Therapy

Completed

Genotype-Guided Warfarin Therapy Trial (WARFPGX)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism | Artificial Heart Valve

United States
AstraZeneca

Completed

Long-term Safety in Atrial Fibrillation Patients

Persistent or Permanent Nonvalvular Atrial Fibrillation
Daiichi Sankyo, Inc.
The TIMI Study Group

Completed

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation (EngageAFTIMI48)

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Italy, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, India, Romania, Russian Federation, Serbia, South Africa, Turkey, Korea, Republic of and more
AstraZeneca

Completed

Interaction Between ABT-335, Rosuvastatin and Warfarin

Healthy

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding. (HEPACO)

Acute Gastrointestinal Bleeding

Spain
Intermountain Health Care, Inc.
Deseret Foundation; LDS Hospital Cardiovascular Research

Completed

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

United States
Woman's Health University Hospital, Egypt

Terminated

Warfarine in Unexplained Oligohydramnios

Oligohydramnios

Egypt
Pfizer

Completed

Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691

Hepatitis C Virus

United States
University of Edinburgh
NHS Lothian

Completed

Cardiovascular Effects of Apelin In Healthy Volunteers

Healthy

United Kingdom
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin

Healthy

United States
University of Alberta

Completed

Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial

Anticoagulation

Canada
Hamilton Health Sciences Corporation
The Physicians' Services Incorporated Foundation

Completed

Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients

Venous Thrombosis | Atrial Fibrillation | Heart Valve Diseases

Canada
Hangzhou Grand Biologic Pharmaceutical, Inc.
Peking Union Medical College Hospital

Unknown

Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects

Healthy Participants

China
Genor Biopharma Co., Ltd.

Unknown

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Rheumatoid Arthritis

China
University of Utah
Roche Diagnostics

Completed

Fearon Algorithm in Warfarin Patient Self-Management

Atrial Fibrillation | Heart Valve Diseases | Venous Thromboses

United States
Novo Nordisk A/S

Completed

Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment

Healthy | Haemostasis

United States
Pfizer

Completed

The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Urinary Bladder, Overactive

United States
Medco Health Solutions, Inc.
Mayo Clinic; Washington University School of Medicine

Completed

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings (MHSMayoWarf1)

Vascular Diseases | Embolism | Embolism and Thrombosis | Thrombosis | Thromboembolism | Venous Thromboembolism | Warfarin

United States
Novo Nordisk A/S

Completed

Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany
Montreal Heart Institute
Roche Diagnostic Ltd.

Completed

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy (ESCAPE)

Quality of Life | Anticoagulants | Drug Monitoring | Pharmacy | Ambulatory Care

Canada
University of Texas Southwestern Medical Center

Withdrawn

Biological Effect of Warfarin on Pancreatic Cancer

Pancreatic Cancer

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism

COPD Exacerbation | PTE - Pulmonary Thromboembolism

China
University of Campania "Luigi Vanvitelli"
Federico II University; University of Salerno

Unknown

Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity (VIALE)

Atrial Fibrillation | Thrombus Due to Heart Valve Prosthesis

Italy
The Cooper Health System

Completed

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

Metachromatic Leukodystrophy

United States
Azienda Ospedaliera Universitaria Policlinico

Completed

Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants (DACUS)

Deep Vein Thrombosis
University of British Columbia

Completed

Warfarin Patient Self-Monitoring

Atrial Fibrillation

Canada
Can-Fite BioPharma

Completed

Safety and Efficacy Study of CF101 to Treat Psoriasis

Plaque Psoriasis

Israel
Peshawar Institute of Cardiology
Getz Pharma

Recruiting

Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial (WRAP)

Left Ventricular Thrombus

Pakistan

Search clinical trials for: Warfarin 3mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations